Recruiting
Phase 2

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04560673

Conditions

Chemotherapy-Induced Peripheral Neuropathy

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Duloxetine

Neurofeedback

Quality-of-Life Assessment

Questionnaire Administration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information